Zeljko Krznaric
Overview
Explore the profile of Zeljko Krznaric including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
126
Citations
3723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lenti M, Hammer H, Tacheci I, Burgos R, Schneider S, Foteini A, et al.
United European Gastroenterol J
. 2025 Mar;
PMID: 40088199
Malabsorption is a complex and multifaceted condition characterised by the defective passage of nutrients into the blood and lymphatic streams. Several congenital or acquired disorders may cause either selective or...
2.
Zonjic J, Karacic A, Brodic I, Starcevic A, Renko I, Krznaric Z, et al.
Nutrients
. 2025 Mar;
17(5).
PMID: 40077799
: The application of whole fermented foods in sports nutrition for gut microbiota personalization is a promising area of investigation. Sauerkraut, a traditional fermented food, has not been extensively studied...
3.
Joly F, Jezerski D, Pape U, Crivelli A, Hutterer E, Bergoin C, et al.
Clin Nutr
. 2025 Feb;
47:54-67.
PMID: 39986179
Background And Aim: Teduglutide is a glucagon-like peptide-2 analogue used to promote intestinal rehabilitation and decrease the dependence from intravenous supplementation (IVS) in patients with short bowel syndrome and intestinal...
4.
Kovacic J, Amidzic Klaric D, Turk N, Krznaric Z, Riordan E, Mornar A
Pharmaceuticals (Basel)
. 2025 Jan;
18(1).
PMID: 39861185
Background/objectives: Janus kinase inhibitors open new horizons for small-molecule drugs in treating inflammatory bowel disease, with ritlecitinib demonstrating significant efficacy in clinical trials for ulcerative colitis and Crohn's disease. Ritlecitinib,...
5.
Karacic A, Zonjic J, Stefanov E, Radolovic K, Starcevic A, Renko I, et al.
Nutrients
. 2025 Jan;
16(24.
PMID: 39771042
Background: Since the gut microbiota is important for athlete health and performance, its optimization is increasingly gaining attention in sports nutrition, for example, with whole fermented foods. Sauerkraut is a...
6.
Karacic A, Renko I, Krznaric Z, Klobucar S, Liberati Prso A
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457576
: The phyla Firmicutes and Bacteroidetes are the main constituents of the gut microbiota. An imbalance in the gut microbiota is a sign of dysbiosis, and the Firmicutes-to-Bacteroidetes ratio has...
7.
Kovacic J, Amidzic Klaric D, Turk N, Krznaric Z, Mornar A
Heliyon
. 2024 Jul;
10(13):e34066.
PMID: 39071639
Etrasimod, a novel selective sphingosine-1-phosphate receptor modulator, was recently approved by the U.S. Food and Drug Administration and the European Medicinal Agency for the treatment of moderately to severely active...
8.
Cobal S, Bender D, Gajdos Kljusuric J, Rumora Samarin I, Krznaric Z
Children (Basel)
. 2024 Jul;
11(7).
PMID: 39062316
Background: Childhood obesity is a global public health concern. Development of effective public health interventions represents the only viable option for decreasing the prevalence of childhood obesity. The objective of...
9.
Klek S, Del Rio Requejo I, Hardy G, Francisco L, Abbasoglu O, Acosta J, et al.
Nutrition
. 2024 Mar;
123:112396.
PMID: 38554461
Objective: Parenteral nutrition represents a therapeutic option for patients with type 3 intestinal failure. If used exclusively, parenteral nutrition has to be complete to provide all essential nutrients. The aim...
10.
Krznaric Z, Bender D, Kovac M, Cuerda C, van Ginkel-Res A, Hiesmayr M, et al.
Clin Nutr
. 2024 Mar;
43(6):1678-1683.
PMID: 38471980
Primary care healthcare professionals (PCHPs) are pivotal in managing chronic diseases and present a unique opportunity for nutrition-related disease prevention. However, the active involvement of PCHPs in nutritional care is...